Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Benzothiadiazine suppression of insulin release from normal and abnormal islet tissue in man.
S S Fajans, … , E M Guntsche, J W Conn
S S Fajans, … , E M Guntsche, J W Conn
Published April 1, 1966
Citation Information: J Clin Invest. 1966;45(4):481-492. https://doi.org/10.1172/JCI105362.
View: Text | PDF
Research Article

Benzothiadiazine suppression of insulin release from normal and abnormal islet tissue in man.

  • Text
  • PDF
Abstract

Authors

S S Fajans, J C Floyd Jr, R F Knopf, J Rull, E M Guntsche, J W Conn

×

Total citations by year

Year: 2019 2018 2017 2015 2014 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 1999 1998 1996 1994 1993 1992 1991 1989 1988 1987 1986 1985 1984 1983 1982 1981 1979 1978 1977 1976 1975 1974 1973 1972 1971 1970 1969 1968 1967 1966 1962 Total
Citations: 1 3 1 1 1 1 1 2 2 2 1 1 3 3 1 1 1 1 2 1 1 2 2 5 1 6 2 3 4 3 4 2 3 2 4 3 5 2 2 6 3 4 17 7 2 1 126
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (126)

Title and authors Publication Year
Les médicaments cardiovasculaires qui favorisent le diabète
B Vergès
Archives des Maladies du Coeur et des Vaisseaux - Pratique 2019
Peptide receptor radionuclide therapy with 177Lu-DOTA-TATE as a promising treatment of malignant insulinoma: a series of case reports and literature review
D Magalhães, IL Sampaio, G Ferreira, P Bogalho, D Martins-Branco, R Santos, H Duarte
Journal of Endocrinological Investigation 2018
Zinc complexes of 3-pyrimidinyl-benzo-1,2,4-thiadiazine
K Pringouri, MU Anwar, BJ Leontowicz, JM Rawson
Polyhedron 2018
A novel bis-1,2,4-benzothiadiazine pincer ligand: synthesis, characterization and first row transition metal complexes
K Pringouri, MU Anwar, L Mansour, N Doupnik, Y Beldjoudi, EL Gavey, M Pilkington, JM Rawson
Dalton Transactions 2018
Pediatric Hypertension
J Flynn, JR Ingelfinger, K Redwine
Pediatric Hypertension 2017
Insulinoma: Literature’s Review (2)
S AlJadir
2015
Copper-promoted aerial oxidation of benzothiadiazines: access to benzothiadiazine S-oxide heterocycles
ER Clark, JJ Hayward, BJ Leontowicz, MU Anwar, M Pilkington, JM Rawson
Dalton Transactions 2014
Successful Control of Intractable Hypoglycemia Using Radiopharmaceutical Therapy with Strontium-89 in a Case with Malignant Insulinoma and Bone Metastases
A Naganuma, H Mayahara, C Morizane, Y Ito, A Hagihara, S Kondo, H Ueno, J Itami, T Okusaka
Japanese Journal of Clinical Oncology 2012
Annual Reports in Medicinal Chemistry
JJ Liu, TW Lee
Annual Reports in Medicinal Chemistry Volume 46 2011
Textbook of Diabetes
PM Jones, SJ Persaud
Textbook of Diabetes 2010
Vitamins & Hormones
KJ Hare, FK Knop
Vitamins & Hormones 2010
Obesity and Hypertension
FX Pi-Sunyer
Obesity Management 2009
Successful Control of Intractable Hypoglycemia Using Rapamycin in an 86-Year-Old Man with a Pancreatic Insulin-Secreting Islet Cell Tumor and Metastases
ME Bourcier, A Sherrod, M DiGuardo, AI Vinik
The Journal of clinical endocrinology and metabolism 2009
Weight loss in obese men by caloric restriction and high-dose diazoxide–mediated insulin suppression
G Boekel, S Loves, A Sorge, J Ruinemans-Koerts, T Rijnders, H Boer
Diabetes, Obesity and Metabolism 2008
Renin–angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans
R Sarzani, F Salvi, P Dessì-Fulgheri, A Rappelli
Journal of Hypertension 2008
A Meta-Analysis of 94,492 Patients With Hypertension Treated With Beta Blockers to Determine the Risk of New-Onset Diabetes Mellitus
S Bangalore, S Parkar, E Grossman, FH Messerli
The American Journal of Cardiology 2007
Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial
SE Kjeldsen, S Julius, G Mancia, GT McInnes, T Hua, MA Weber, A Coca, S Ekman, X Girerd, K Jamerson, P Larochelle, TM MacDonald, RE Schmieder, MA Schork, P Stolt, R Viskoper, J Widimský, A Zanchetti
Journal of Hypertension 2006
Antihypertensive drugs and incidence of type 2 diabetes: Evidence and implications for clinical practice
S Asfaha, R Padwal
Current Hypertension Reports 2005
Therapeutic Controversies in Hypertension
FH Messerli, E Grossman
Seminars in Nephrology 2005
Mechanism, temporal patterns, and magnitudes of the metabolic responses to the K ATP channel agonist diazoxide
B Raju, PE Cryer
American journal of physiology. Endocrinology and metabolism 2005
Insulin secretory characteristics of monkey pancreatic islets: a simple method of islet isolation and the effect of various density gradients on separation
AN Balamurugan, B Ramakrishna, S Gunasekaran
Diabetes Research and Clinical Practice 2004
Old antihypertensives and new diabetes:
LH Opie, R Schall
Journal of Hypertension 2004
Antihypertensive therapy and new onset diabetes:
FH Messerli, E Grossman, G Leonetti
Journal of Hypertension 2004
Handbook of Obesity: Etiology and Pathophysiology, Second Edition
R Pasquali, V Vicennati, U Pagotto
Handbook of Obesity: Etiology and Pathophysiology, Second Edition 2003
Comparison of effects of captopril used either alone or in combination with a thiazide diuretic on insulin action in hypertensive Type 2 diabetic patients: a double-blind crossover study
SJ Hunter, MI Wiggam, CN Ennis, HM Whitehead, B Sheridan, AB Atkinson, PM Bell
Diabetic Medicine 1999
Effects of combination therapy with an angiotensin converting enzyme inhibitor and thiazide diuretic on insulin action in essential hypertension
SJ Hunter, R Harper, CN Ennis, E Crothers, B Sheridan, GD Johnston, AB Atkinson, PM Bell
Journal of Hypertension 1998
Thiazide-induced hyperglycaemia: A role for calcium-activated potassium channels?
P Pickkers, M Schachter, AD Hughes, MD Feher, PS Sever
Diabetologia 1996
Effects of low dose versus conventional dose thiazide diuretic on insulin action in essential hypertension
R Harper, CN Ennis, B Sheridan, AB Atkinson, GD Johnston, PM Bell
BMJ (Clinical research ed.) 1994
The countering of diazoxide-induced vasodilatation by tenoxicam in normal volunteers
KD Sommers, M van Wyk, JR Snyman
European Journal of Clinical Pharmacology 1994
Insulin Resistance and Hypertension
P Passa
Clinical and Experimental Hypertension 1993
8 Drug-induced diabetes
RE Ferner
Baillière's Clinical Endocrinology and Metabolism 1992
25 Years of Successful Diazoxide and Trichlormethiazide Treatment of Hyperinsulinism in a 79-Year-Old Woman
JC Hoffmann, CB Cook, JC Floyd
Drug Investigation 1991
Therapeutic Approach to Hypertension in the Elderly
JR Sowers, S Khoury, K Imam, R Byyny
Primary care 1991
Insulin-Producing Islet Cell Tumors
SS Fajans, AI Vinik
Endocrinology and metabolism clinics of North America 1989
Treatment of Endocrine Tumors of the Pancreas
AI Vinik, AR Moattari
Endocrinology and metabolism clinics of North America 1989
Antihypertensive therapy in diabetic patients
AD Harrower, G McFarlane
The American Journal of Medicine 1988
Antihypertensive tehrapy in diabetic patients
AD Harrower, G McFarlane
The American Journal of Medicine 1988
The effects of antihypertensive drugs on glucose intolerance in hypertensive nondiabetics and diabetics
MC Houston
American Heart Journal 1988
Clinically Significant Diuretic-Induced Glucose Intolerance
NK Lowder, HI Bussey, NJ Sugarek
1988
Effects of the diuretic furosemide on the sensitivity of glycolysis and glycogen synthesis to insulin in the soleus muscle of the rat
G Dimitriadis, B Leighton, M Parry-Billings, E A Newsholme
Diabetologia 1988
Pharmacological treatment of lipid disorders in diabetes mellitus
MF Lopes-Virella, JA Colwell
Diabetes / Metabolism Reviews 1987
Somatostatin analogue (SMS 201-995) in the management of gastroenteropancreatic tumors and diarrhea syndromes
AI Vinik, S Tsai, AR Moattari, P Cheung, FE Eckhauser, K Cho
The American Journal of Medicine 1986
The Role of a Long-Acting Somatostatin Analogue (SMS 201-995) in the Management of a Patient with a Benign Insulin-Secreting Adenoma of the Pancreas and a Postoperative Pancreatic Fistula
E Lewis, S Tsai, A Vinik
Scandinavian Journal of Gastroenterology 1986
Adverse Effects of Antihypertensive Drug Therapy on Glucose Intolerance
MC Houston
Cardiology Clinics 1986
Clinical Endocrinology
A Labhart
Clinical Endocrinology 1986
Diuretika III
F Krück, A Schrey
1986
The Effects of Antihypertensive Drugs on Serum Lipids and Lipoproteins I. Diuretics1:
RP Ames
Drugs 1986
Diazoxide Treatment of Neonatal and Infant Hypoglycemia: A Review and Reassessment
TW AvRuskin, JF Crigler, JS Soeldner
Journal of Pediatric Endocrinology and Metabolism 1985
Effect of indapamide on blood pressure and glucose tolerance in non-insulin-dependent diabetes
AD Harrower, G McFarlane, T Donnelly, CE Gray
Hypertension 1985
Furosemide inhibits glucose transport in isolated rat adipocytes via direct inactivation of carrier proteins
DB Jacobs, BK Mookerjee, CY Jung
Journal of Clinical Investigation 1984
Diagnostik und Operation eines Insulinoms unter Einsatz eines glukosekontrollierten Insulininfusionssystems (GCIIS)
G Müller-Esch, A Valesky, U Weber, G Wood
Klinische Wochenschrift 1984
Diagnosis and Management of Endocrine-related Tumors
RJ Santen, A Manni
1984
Treatment of diabetes with insulin. From art to science
MC Riddle
The Western journal of medicine 1983
Negative effects of diuretic drugs on metabolic risk factors for coronary heart disease: Possible alternative drug therapies
RP Ames
The American Journal of Cardiology 1983
Metabolic disturbances increasing the risk of coronary heart disease during diuretic-based antihypertensive therapy: Lipid alterations and glucose intolerance
RP Ames
American Heart Journal 1983
Thiazide-induced disturbances in carbohydrate, lipid, and potassium metabolism
E Perez-Stable, PV Caralis
American Heart Journal 1983
Haemodynamic and metabolic effects of diazoxide during rest and forearm exercise
OJ Hartling, TL Svendsen, J Trap-Jensen
European Journal of Clinical Pharmacology 1982
Type I multiple endocrine neoplasias
RJ Vieto, RC Hickey, NA Samaan
Current Problems in Cancer 1982
Improvement of glucose tolerance and lowering of glycohemoglobin and serum lipid concentrations after discontinuation of antihypertensive drug therapy
RP Ames, P Hill
Circulation 1982
Impairment of glucose tolerance produced by diuretics and other drugs
BL Furman
Pharmacology & Therapeutics 1981
Effects of diazoxide on insulin secretion and metabolic efficiency in the db/db mouse
S Lee
Life Sciences 1981
Clinical Pharmacology of Sulphonylurea Hypoglycaemic Agents: Part 2
JE Jackson, R Bressler
Drugs 1981
Decrease of some metabolic and physiologic effects of diazoxide by propranolol in rat.
Johansson SR, Andersson RG
Naunyn-Schmiedeberg's Archives of Pharmacology 1981
Calcium infusion: a new provocative test for insulinomas
EL Kaplan, AH Rubenstein, R Evans, CH Lee, P Klementschitsch
Annals of Surgery 1979
Insulin release in response to calcium in the diagnosis of insulinoma
BK Roy, J Abuid, H Wendorff, W Nitiyanant, FR DeRubertis, JB Field
Metabolism 1979
The Diabetic Pancreas
GF Cahill
New England Journal of Medicine 1978
Klinik der inneren Sekretion
A Labhart
1978
Beta cell nesidioblastosis
K Becker, U Wendel, H Przyrembel, M Tsotsalas, H Mntefering, HJ Bremer
European Journal of Pediatrics 1978
Changes in the Fasting Blood Sugar After Hydrochlorothiazide and Potassium Supplementation
KA McFARLAND, AA Carr
The Journal of Clinical Pharmacology 1977
Diabetes mellitus • B
R Beckmann, M Berger, A Beringer, P Berchtold, J Beyer, A Bischoff, G Brehm, BF Clarke, GR Constam, LJ Duncan, FA Gries, A Hasselblatt, R Hild, K Irmscher, K Jahnke, J Kühnau, H Liebermeister, K Lundbaek, G Meyer-Schwickerath, S Napp-Mellinghoff, M Neubauer, F Nobbe, K Oberdisse, P Petrides, R Petzoldt, H Sauer, K Schöffling, M Spitznas, J Steinke, M Vogel, KH Vogelberg, A Wessing
1977
IMPROVEMENT IN INSULIN SECRETION IN DIABETES AFTER DIAZOXIDE
RH Greenwood, RF Mahler, CN Hales
The Lancet 1976
13 Selected tests of carbohydrate metabolism
V Marks, KG Alberti
Clinics in Endocrinology and Metabolism 1976
Leucinempfindliche Hypoglyk�mie: Verlaufsbeobachtungen unter Behandlung mit Diazoxid
T Lcking
European Journal of Nuclear Medicine 1976
Morphologic effects of diazoxide and diphenylhydantoin on insulin secretion and biosynthesis in b cells of mice
G Bommer, , G Klppel
Virchows Archiv A Pathological Anatomy and Histopathology 1976
Drug interactions in cardiovascular therapy
J Koch-Weser
American Heart Journal 1975
Pancreatic Islet-Cell Toxicity
LJ Fischer, DE Rickert, A Lazarow
Critical Reviews in Toxicology 1975
Diabetes mellitus · A
E Cerasi, P Dieterle, H Ege, A Englhardt, H Frerichs, W Gepts, A Hasselblatt, HR Henrichs, L Herberg, JJ Hoet, H Hungerland, K Jahnke, RJ Jarrett, G Jörgensen, KH Jørgensen, H Kasemir, H Keen, L Kerp, V Leclercq-Meyer, H Liebermeister, G Löffler, R Luft, WJ Malaisse, J Markussen, M Möllering, H Schadewaldt, J Schlichtkrull, K Schöffling, U Schwedes, PC Scriba, F Sundby, KH Usadel, L Weiss, H Zimmermann, K Oberdisse
1975
Characterization of cyclic 3', 5'-nucleotide phosphodiesterase activity in an islet cell tumor of the syrian hamster
UK Schubart, L Udem, SG Baum, OM Rosen
Molecular and Cellular Endocrinology 1974
Insulin values of normal pancreatic and pancreatic adenomas tissue extracts in children
A Castro, N Buist, D Grettie, F Bartos
Biochemical Medicine 1974
Effect of diazoxide in plasma glucose and insulin concentrations after acute glycemic stimulation and intravenous tolbutamide
A Castro, DP Grettie
Biochemical Medicine 1974
Pharmacotherapy of Hormone-Secreting Tumours
H Frerichs, NS Track
1974
Insulinoma: Natural History and Diagnosis
VI Marks, E Samols
1974
A controlled study of clopamide, clorexolone, and hydrochlorothiazide in diabetics
BH Hicks, JD Ward, RJ Jarrett, H Keen, P Wise
Metabolism 1973
The effect of diazoxide in children with islet cell adenomas
A Castro, K Dyess, N Buist, J Potts
Clinical Biochemistry 1973
Familial nesidioblastosis as the predominant manifestation of multiple endocrine adenomatosis
JE Vance, RW Stoll, AE Kitabchi, KD Buchanan, D Hollander, RH Williams
The American Journal of Medicine 1972
Insulin-Secreting Tumors of the Pancreas: A Diagnostic and Therapeutic Challenge
P Koutras, RR White
Surgical Clinics of North America 1972
Diazoxide effects on biphasic insulin release: “adrenergic” suppression and enhancement in the perifused rat pancreas
IM Burr, EB Marliss, W Stauffacher, AE Renold
Journal of Clinical Investigation 1971
Hyperresponsiveness to tolbutamide of dogs pretreated with diazoxide
JH Anderson, GW Byrd, WG Blackard
Metabolism 1971
A044: An improved hyperglycemic agent
N Lopez, J Basabe, A Grant, S Krees, M Terry, J Viktora, F Wolff
Metabolism 1971
Inhibition of mitochondrial metabolism by the diabetogenic thiadiazine diazoxide—I
G Schäfer, R Portenhauser, R Trolp
Biochemical Pharmacology 1971
Inhibition of mitochondrial metabolism by the diabetogenic thiadiazine diazoxide—II
R Portenhauser, G Schäfer, R Trolp
Biochemical Pharmacology 1971
Diazoxide: A Review of its Pharmacological Properties and Therapeutic Use in Hypertensive Crises
Na
Drugs 1971
The Antihypertensive Properties of Furosemide On Chronic Oral Administration
LC Johnston, DE Santos, C Gantt
The Journal of Clinical Pharmacology and The Journal of New Drugs 1970
The Structure and Metabolism of the Pancreatic Islets
A Lambert, L Orci, Y Kanazawa, A Renold, C Rouiller
The Structure and Metabolism of the Pancreatic Islets 1970
The effect of agents used in the treatment of bronchial asthma on carbohydrate metabolism and histamine sensitivity after beta-adrenergic blockade
RG Townley, D Daley, W Selenke
Journal of Allergy 1970
Role of gastro-intestinal factors in reactive hypoglycemia
E Veverbrants, W Olsen, RA Arky
Metabolism 1969
Schering Symposium on Endocrinology, Berlin, May 26 to 27, 1967
SS Fajans, JC Floyd, RF Knopf, JW Conn
Schering Symposium on Endocrinology, Berlin, May 26 to 27, 1967 1969
Diazoxide, an inhibitor of succinate oxidation
G S, C W, R Porten, D Boj
Biochemical Pharmacology 1969
La diazoxide: meccanismo della azione iperglicemizzante e possibilit� di impiego terapeutico
P Brunetti, F Santeusanio
Acta Diabetologica 1969
INSULIN SECRETORY BLOCKADE BY BENZOTHIADIAZINES AND CATECHOLAMINES: REVERSAL BY SULFONYLUREAS
HS Seltzer, JR Crout
Annals of the New York Academy of Sciences 1968
FURTHER STUDIES ON DIAZOXIDE SUPPRESSION OF INSULIN RELEASE FROM ABNORMAL AND NORMAL ISLET TISSUE IN MAN
SS Fajans, JC Floyd, CA Thiffault, RF Knopf, TS Harrison, JW Conn
Annals of the New York Academy of Sciences 1968
MECHANISM OF DIAZOXIDE HYPERGLYCEMIA IN ANIMALS
II Tabachnick, A Gulbenkian
Annals of the New York Academy of Sciences 1968
BIOCHEMICAL ASPECTS OF THE HYPERGLYCEMIC ACTION OF DIAZOXIDE
G Senft
Annals of the New York Academy of Sciences 1968
CLINICAL EXPERIENCE WITH DIAZOXIDE
LC Wegienka, RG Simpson, JH Karam, PH Forsham
Annals of the New York Academy of Sciences 1968
DIAZOXIDE AND THE TREATMENT OF HYPOGLYCEMIA: AN HISTORICAL REVIEW
J Black
Annals of the New York Academy of Sciences 1968
THE EFFECTS OF DIAZOXIDE AND BENZOTHIADIAZINE DIURETICS UPON PHOSPHODIESTERASE
PF Moore
Annals of the New York Academy of Sciences 1968
STUDIES IN A PATIENT WITH RETROPERITONEAL SARCOMA ASSOCIATED WITH SEVERE HYPOGLYCEMIA
WR Tucker, WG Ryan, BF Martin, TB Schwartz
Annals of the New York Academy of Sciences 1968
THE THERAPEUTIC APPLICATION OF DIAZOXIDE IN PEDIATRIC HYPOGLYCEMIC STATES
A Drash, F Kenny, J Field, R Blizzard, H Langs, F Wolff
Annals of the New York Academy of Sciences 1968
DIAZOXIDE THERAPY OF INTRACTABLE HYPOGLYCEMIA
V Marks, E Samols
Annals of the New York Academy of Sciences 1968
METABOLIC EFFECTS OF DIAZOXIDE IN NORMAL SUBIECTS, PATIENTS WITH DIABETES MELLITUS, AND PATIENTS WITH ORGANIC HYPOGLYCEMIA
J Steinke, JS Soeldner
Annals of the New York Academy of Sciences 1968
CLINICAL AND PHYSIOLOGIC STUDIES USING DIAZOXIDE IN THE TREATMENT OF HYPOGLYCEMIA
JB Field, C Boyle, A Remer, T Drapanas
Annals of the New York Academy of Sciences 1968
FIDDLER'S HORNER'S SYNDROME
TM Mitchell-Fox
The Lancet 1968
EFFECT OF ETHACRYNIC ACID AND OTHER DIURETICS ON GLUCOSE UTILISATION BY ADIPOSE TISSUE
F Fallucca, G Aliberti, G Tamburrano, G Menzinger
The Lancet 1968
Carbohydrate Metabolism
M Cornblath
Carbohydrate Metabolism 1968
Toxic effects of a chlorothiazide-diazoxide combination on adipose tissue and kidneys of intact rats
HP Settle, WJ Munsie, JA Owen
Diabetologia 1968
Nebenschilddrüse und endokrine Regulationen des Calciumstoffwechsels: Spontan-Hypoglykämie. Glucagon
J Kracht
1968
Diazoxide blood levels in man
S Symchowicz, L Winston, J Black, M Smith, B Calesnick, II Tabachnick
Journal of Pharmaceutical Sciences 1967
Metabolism of plasma glucose and lipids following diazoxide administration in dogs
SS Sanbar
Metabolism 1967
Diazoxide treatment of idiopathichypoglycemia of infancy
L Baker, R Kaye, AW Root, AL Prasad
The Journal of Pediatrics 1967
Proceedings of the 1966 Laurentian Hormone Conference
AM Bongiovanni, WR Eberlein, AS Goldman, M New
Proceedings of the 1966 Laurentian Hormone Conference 1967
Hypoglycemia and the Central Nervous System
JE Etheridge
Pediatric Clinics of North America 1967
Hypoglycemia In Infancy: Appraisal of the Problem, Methods of Investigation, Possible Association of Cataracts
JM Cohen, DC de Vivo, DG Cogan, JF Crigler
Clinical Pediatrics 1967
The influence of chlorpropamide pre-treatment on insulin and growth hormone release after arginine
L Riggs, D Rabinowitz, TJ Merimee
Postgraduate medical journal 1967
Diazoxide in the Treatment of Infantile Hypoglycemia
TR Mereu, A Kassoff, AD Goodman
New England Journal of Medicine 1966
[Insulin secretion in vitro. II. Inhibition of glucose induced insulin release by diazoxide].
Frerichs H, Gerber R, Creutzfeldt W
Diabetologia 1966
Antihypertensive Agents
ED Freis
New England Journal of Medicine 1962

← Previous 1 2 3 4 5 6 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts